Directorio de personas
Diego Arango Del Corro

Diego Arango Del Corro

Grado: Doctor/a


darango(ELIMINAR)@irblleida.cat

ResearcherID: http://www.researcherid.com/rid/M-5667-2016

Publicaciones

  • Vanharanta S; Wortham NC; Laiho P; Sjöberg J; Aittomäki K; Arola J; Tomlinson IP; Karhu A; Arango D; Aaltonen LA

    7q deletion mapping and expression profiling in uterine fibroids.

    ONCOGENE 24 6545-6554. .

    [doi:10.1038/sj.onc.1208784]

  • Arango D; Laiho P; Kokko A; Alhopuro P; Sammalkorpi H; Salovaara R; Nicorici D; Hautaniemi S; Alazzouzi H; Mecklin JP; Järvinen H; Hemminki A; Astola J; Schwartz S; Aaltonen LA

    Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer.

    Gastroenterology 129 874-884. .

    [doi:10.1053/j.gastro.2005.06.066]

  • Kruhøffer M; Jensen JL; Laiho P; Dyrskjøt L; Salovaara R; Arango D; Birkenkamp-Demtroder K; Sørensen FB; Christensen LL; Buhl L; Mecklin JP; Järvinen H; Thykjaer T; Wikman FP; Bech-Knudsen F; Juhola M; Nupponen NN; Laurberg S; Andersen CL; Aaltonen LA; Ørntoft TF

    Gene expression signatures for colorectal cancer microsatellite status and HNPCC.

    BRITISH JOURNAL OF CANCER 92 2240-2248. .

    [doi:10.1038/sj.bjc.6602621]

  • Mariadason JM; Nicholas C; L'Italien KE; Zhuang M; Smartt HJ; Heerdt BG; Yang W; Corner GA; Wilson AJ; Klampfer L; Arango D; Augenlicht LH

    Gene expression profiling of intestinal epithelial cell maturation along the crypt-villus axis.

    Gastroenterology 128 1081-1088. .

    [doi:10.1053/j.gastro.2005.01.054]

  • Arango D; Wilson AJ; Shi Q; Corner GA; Arañes MJ; Nicholas C; Lesser M; Mariadason JM; Augenlicht LH

    Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells.

    BRITISH JOURNAL OF CANCER 91 1931-1946. .

    [doi:10.1038/sj.bjc.6602215]

  • Oliveira C; Westra JL; Arango D; Ollikainen M; Domingo E; Ferreira A; Velho S; Niessen R; Lagerstedt K; Alhopuro P; Laiho P; Veiga I; Teixeira MR; Ligtenberg M; Kleibeuker JH; Sijmons RH; Plukker JT; Imai K; Lage P; Hamelin R; Albuquerque C; Schwartz S; Lindblom A; Peltomaki P; Yamamoto H; Aaltonen LA; Seruca R; Hofstra RM

    Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status.

    HUMAN MOLECULAR GENETICS 13 2303-2311. .

    [doi:10.1093/hmg/ddh238]

  • Mariadason JM; Arango D; Augenlicht LH

    Customizing chemotherapy for colon cancer: the potential of gene expression profiling.

    DRUG RESISTANCE UPDATES 7 209-218. .

    [doi:10.1016/j.drup.2004.05.001]

  • Mariadason JM; Arango D; Shi Q; Wilson AJ; Corner GA; Nicholas C; Aranes MJ; Lesser M; Schwartz EL; Augenlicht LH

    Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin.

    CANCER RESEARCH 63 8791-8812. .

  • Klampfer L; Huang J; Corner G; Mariadason J; Arango D; Sasazuki T; Shirasawa S; Augenlicht L

    Oncogenic Ki-ras inhibits the expression of interferon-responsive genes through inhibition of STAT1 and STAT2 expression.

    Journal Of Biological Chemistry 278 46278-46287. .

    [doi:10.1074/jbc.M304721200]

  • Arango D; Mariadason JM; Wilson AJ; Yang W; Corner GA; Nicholas C; Aranes MJ; Augenlicht LH

    c-Myc overexpression sensitises colon cancer cells to camptothecin-induced apoptosis.

    BRITISH JOURNAL OF CANCER 89 1757-1765. .

    [doi:10.1038/sj.bjc.6601338]

  • Wilson AJ; Arango D; Mariadason JM; Heerdt BG; Augenlicht LH

    TR3/Nur77 in colon cancer cell apoptosis.

    CANCER RESEARCH 63 5401-5407. .

  • Augenlicht LH; Velcich A; Klampfer L; Huang J; Corner G; Aranes M; Laboisse C; Rigas B; Lipkin M; Yang K; Shi Q; Lesser M; Heerdt B; Arango D; Yang W; Wilson A; Mariadason JM

    Application of gene expression profiling to colon cell maturation, transformation and chemoprevention.

    Journal Of Nutrition 133 -. .

    [doi:10.1093/jn/133.7.2410S]

Proyectos

  • Contratos predoctorales de formación en investigación en salud (PFIS)
  • Nueva aproximación terapéutica para el cáncer colorectal.
  • EPH Receptor Signaling in Endometrial Cancer
  • Antioxidant treatment as a novel therapeutic option for microvillus inclusion disease. ARMED
  • Programa d'Impuls al Talent i l'Ocupabilitat (2021-2024)
  • Nueva estrategia terapéutica para ael cáncer gástrico basada en la modulación de la señalización de RHOA
  • Desarrollo de nanosistemas de marcaje de CXCR4 mediante radiosondas para la imagen molecular de células tumorales y del microambiente tumoral
  • Identificación de nuevos biomarcadores de respuesta a los compuestos regorafenib y TAS-102 en pacientes con cáncer colorrectal.
  • Targeting tumor microevironment by a translational multivalent nanomedicine: towards an effective anticancer combination immunotherapy